IN2012MN02606A - - Google Patents

Info

Publication number
IN2012MN02606A
IN2012MN02606A IN2606MUN2012A IN2012MN02606A IN 2012MN02606 A IN2012MN02606 A IN 2012MN02606A IN 2606MUN2012 A IN2606MUN2012 A IN 2606MUN2012A IN 2012MN02606 A IN2012MN02606 A IN 2012MN02606A
Authority
IN
India
Prior art keywords
volatile solvent
formulation
poly
system including
solvent system
Prior art date
Application number
Other languages
English (en)
Inventor
Hyder Aliyar
Jie Zhang
Original Assignee
Nuvo Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvo Res Inc filed Critical Nuvo Res Inc
Publication of IN2012MN02606A publication Critical patent/IN2012MN02606A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN2606MUN2012 2010-05-06 2011-05-04 IN2012MN02606A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33215710P 2010-05-06 2010-05-06
PCT/US2011/035216 WO2011140236A2 (fr) 2010-05-06 2011-05-04 Formulations d'acétonide de triamcinolone pour le traitement de dermatite et du psoriasis

Publications (1)

Publication Number Publication Date
IN2012MN02606A true IN2012MN02606A (fr) 2015-05-22

Family

ID=44904454

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2606MUN2012 IN2012MN02606A (fr) 2010-05-06 2011-05-04

Country Status (9)

Country Link
US (1) US20130338127A1 (fr)
EP (1) EP2566456A4 (fr)
JP (1) JP2013528590A (fr)
CN (1) CN102970974B (fr)
AU (1) AU2011248162A1 (fr)
BR (1) BR112012028267A2 (fr)
CA (1) CA2798316A1 (fr)
IN (1) IN2012MN02606A (fr)
WO (1) WO2011140236A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US20070196452A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Flux-enabling compositions and methods for dermal delivery of drugs

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107161A (en) * 1972-05-13 1978-08-15 J. Uriach & Cia. S.A. Bis(triamcinolone acetonide)-4,4'-methylenebis-(3-methoxy-2-naphthoate)
JPS62263120A (ja) * 1986-05-09 1987-11-16 Sekisui Chem Co Ltd 貼付剤
US20040141925A1 (en) * 1998-11-12 2004-07-22 Elan Pharma International Ltd. Novel triamcinolone compositions
US6830758B2 (en) * 2001-04-02 2004-12-14 Lectec Corporation Psoriasis patch
RU2322984C2 (ru) * 2001-10-05 2008-04-27 Комбинаторкс, Инкорпорейтед Комбинации для лечения иммуновоспалительных расстройств
KR100843001B1 (ko) * 2002-01-16 2008-07-01 동화약품공업주식회사 구강점막 부착형 필름제제
US20030185915A1 (en) * 2002-03-28 2003-10-02 Jaime Carlo Synergetic composition for the treatment of psoriasis and other skin disorders and method therefor
TR200201556A2 (tr) * 2002-06-12 2004-01-21 Orva İlaç Sanayi̇ Ve Ti̇caret A. Ş. Kortikosteroid ve nonsteroidal antienflamatuar içeren farmasötik bileşim
US8741333B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
JP2009519958A (ja) * 2005-12-14 2009-05-21 ザーズ， インコーポレイテッド 薬物の皮膚送達のための、フラックス化可能な組成物および方法

Also Published As

Publication number Publication date
CA2798316A1 (fr) 2011-11-10
WO2011140236A3 (fr) 2012-03-01
AU2011248162A1 (en) 2012-12-20
WO2011140236A2 (fr) 2011-11-10
US20130338127A1 (en) 2013-12-19
EP2566456A4 (fr) 2013-09-25
CN102970974A (zh) 2013-03-13
BR112012028267A2 (pt) 2016-11-01
CN102970974B (zh) 2015-03-04
JP2013528590A (ja) 2013-07-11
EP2566456A2 (fr) 2013-03-13

Similar Documents

Publication Publication Date Title
MY177912A (en) Vegf neutralizing prodrugs for the treatment of ocular conditions
SG10201907588XA (en) Androgen Receptor Modulators And Uses Thereof
CR20140365A (es) Compuestos de carbamato y preparación y uso de los mismos
PE20150668A1 (es) Formulaciones farmaceuticas topicas no acuosas
CL2012001971A1 (es) Compuestos derivados de 1-piperazinil-3-piridin-carboxilato, como bloqueadores de los canales de sodio dependientes de voltaje; composicion farmaceutica; y su uso para el tratamiento de enfermedades respiratorias o del tracto respiratorio tal como asma, epoc, tos, silicosis, entre otras.
CO7160098A2 (es) Suministro de fármaco biodegradable para las composiciones hidrofóbicas
SG10201808743VA (en) Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
WO2014011590A3 (fr) Composition et méthode pour le traitement de la dépression et de la psychose chez l'homme
PH12014502095A1 (en) Estrogen receptor modulators and uses thereof
BR112013003969A2 (pt) composições de resina recicladas e dispositivos médicos descartáveis produzidos delas
CZ308492B6 (cs) Kosmetická kompozice na bázi kyseliny hyaluronové, způsob její přípravy a použití
BR112014030386A8 (pt) Compostos e composições para modular a atividade de egfr
BR112015023001A8 (pt) composições resultantes da retirada de exons para o tratamento de distrofia muscular.
BR112014029206A2 (pt) pós hemostáticos de celulose regenerada oxidada e métodos para fabricação dos mesmos
MX357496B (es) Moduladores del receptor de estrógenos fluorados y sus usos.
BR112013003671A2 (pt) composições e métodos para melhorar os benefícios terapêuticos de compostos químicos administyrados sub-otimamente incluindo hexitóis substituídos tais como dianidrogalactitol e diacetildianidrogalactiol
BR112017004115A2 (pt) composição para cuidados pessoais, e, métodos para aumento da viscosidade e para preparação de uma composição para cuidados pessoais.
DOP2015000303A (es) Letermovir amorfo y formulaciones farmacéuticas sólidas del mismo para administración por vía oral
MX2018000894A (es) Composicion de fragancia a base de agua, dispositivo de suministro de fragancia, y metodo para proporcionar un perfume de larga duracion.
MX2015008021A (es) Composiciones y metodos para administracion transdermica de hormonas y otros agentes medicos.
MX361349B (es) Moduladores del receptor x del higado (lxr) para el tratamiento de enfermedades, trastornos y condiciones dérmicas.
CA2929865C (fr) Vehicule topique pulverisable et composition comprenant de la phosphatidylcholine
MX2016008136A (es) Formulaciones de giberelina con baja cantidad de productos quimicos organicos volatiles.
EP2515912A4 (fr) Composition pharmaceutique comprenant un analogue de la vitamine d et un mélange cosolvant-tensioactif
CR20120236A (es) Formulación líquida de control de plagas